Skip to main content
Premium Trial:

Request an Annual Quote

Karin Eastham, Seiichiro Tsurumaki, J. Mark Lievonen

Premium

Karin Eastham will resign as senior vice president, chief financial officer, treasurer, and secretary of Diversa after the company’s annual shareholder meeting in mid-May. She will continue to consult for Diversa for a period of time.


Seiichiro Tsurumaki has been appointed assistant vice president for Japan of Bruker Daltonics, a company of Bruker Biosciences. He will be responsible for marketing, sales, applications, customer support, and research activities in Japan and will join Bruker’s global management team. Tsurumaki joined Bruker in 2000 as sales and marketing director in Japan. Prior to that, he was MALDI-TOF and LC-MS sales manager at Nihon Perseptive. As part of his new responsibilities, Tsurumaki is expanding the Yokohama Technical Support Center and will also open an Osaka applications laboratory, according to the company.


J. Mark Lievonen has joined the board of directors of Calgary, Canada-based Oncolytics. He is the president of Aventis Pasteur. Since 2003, he has also been a director of the Ontario Genomics Institute board. Lievonen holds an MBA and a bachelor’s degree in business administration from York University.

 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.